文献速递妇科

子宫内膜癌盆腔前哨淋巴结检测标准化的子宫淋巴解剖研究

A study on uterine lymphatic anatomy for standardization of pelvic sentinel lymph node detection in endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2017-02-10

前瞻性连续纳入子宫内膜癌患者,宫颈注射吲哚菁绿60例、宫底注射30例,系统腹膜后定位淋巴引流。识别出上、下宫旁两条恒定盆腔通路,宫颈与宫底注射双侧显示至少一条通路分别为98%与80%(p=0.005)。作者认为应追求两条通路双侧SLN显示,宫颈注射技术成功率更高。

要点

  • 宫颈与宫底注射均可识别上宫旁通路(UPP)和下宫旁通路(LPP)两条恒定盆腔SLN引流路径。
  • 宫颈注射双侧显示至少一条盆腔通路为98%,宫底注射为80%(p=0.005);两条通路均双侧显示分别为30%与20%(p=0.6)。
  • 19%的淋巴结阳性患者中近三分之一沿LPP存在转移;未发现假阴性SLN。

核心结论

  • 基于子宫淋巴解剖,应追求UPP和LPP两条通路均双侧检出至少一枚SLN。
  • LPP未显示时可能需要行完整骶前淋巴结清扫。
  • 盆腔通路及SLN位置与示踪剂注射部位无关,但宫颈注射因技术成功率更高而更可取。

研究设计与样本

  • 前瞻性连续纳入子宫内膜癌女性的研究。
  • 宫颈注射吲哚菁绿60例,宫底注射30例。
  • 行系统性经腹膜和腹膜后子宫淋巴引流定位,比较由传入淋巴管定义的盆腔SLN位置与淋巴结转移。

主要发现

  • 识别出两条恒定盆腔SLN淋巴通路:上宫旁通路(UPP)引流至腹侧髂外和/或闭孔淋巴结,下宫旁通路(LPP)引流至髂内和/或骶前淋巴结。
  • 宫颈注射与宫底注射后双侧显示至少一条盆腔通路分别为98%与80%(p=0.005)。
  • 宫颈注射与宫底注射后双侧显示两条盆腔通路分别为30%与20%(p=0.6),因LPP较少显示。
  • 19%的淋巴结阳性患者中近三分之一沿LPP存在转移。
  • 未发现假阴性SLN。

临床怎么用

  • 作者认为应追求UPP和LPP两条通路均双侧检出至少一枚SLN。
  • 作者认为LPP未显示时可能需要行完整骶前淋巴结清扫。
  • 作者认为宫颈注射因技术成功率更高而更可取。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the anatomy of uterine lymphatic drainage following cervical or fundal tracer injection to enable standardization of a pelvic sentinel lymph node (SLN) concept in endometrial cancer (EC). METHODS: A prospective consecutive study of women with EC was conducted. A fluorescent dye (Indocyanine green) was injected into the cervix (n=60) or the uterine fundus (n=30). A systematic trans- and retroperitoneal mapping of uterine lymphatic drainage was performed. Positions of the pelvic SLNs, defined by afferent lymph vessels, and lymph node metastases were compared. RESULTS: Two consistent lymphatic pathways with pelvic SLNs were identified irrespective of injection site; an upper paracervical pathway (UPP) with draining medial external and/or obturator lymph nodes and a lower paracervical pathway (LPP) with draining internal iliac and/or presacral lymph nodes. Bilateral display of at least one pelvic pathway following cervical and fundal injection occurred in 98% and 80% respectively (p=0.005). Bilateral display of both pelvic pathways occurred in 30% and 20% respectively (p=0.6) as the LPP was less often displayed. Nearly one third of the 19% node positive patients had metastases along the LPP. No false negative SLNs were identified. CONCLUSIONS: Based on uterine lymphatic anatomy a bilateral detection of at least one SLN in both the UPP and LPP should be aimed for. Absence of display of the LPP may warrant a full presacral lymphadenectomy. Although pelvic pathways and positions of SLNs are independent of the tracer injection site, cervical injection is preferable due to a higher technical success rate.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Geppert B, Lönnerfors C, Bollino M, et al. A study on uterine lymphatic anatomy for standardization of pelvic sentinel lymph node detection in endometrial cancer. Gynecol Oncol. 2017. PMID: 28196672. doi:10.1016/j.ygyno.2017.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。